Case study of Suzy
Developing appropriate pharmacological treatment plans requires medical and mental health professionals to consider all potential factors that may be contributing to the client’s psychopathology. Contributing factors may include family history of mental illness (Preston, O’Neal, & Talaga, 2010), personal history, life circumstances, and drug abuse. Additionally, neurotransmitter malfunctions (genetic or self-induced) may manifest as diagnosable mental illnesses. Mental health care teams (e.g., counselors, medical doctors, psychiatrists, psychologists, social workers, and support teams) need to consider all of these factors in diagnosing and treating psychopathology.
For this Discussion, review the document “Neurobiology Considerations Case Study: Suzy” found in this week’s Learning Resources and consider the recommendations you might make to treat Suzy.
300 to 500 words questions in bold then answer this is a discussion not an essay
Post a brief description of the possible pharmacological recommendations for treating Suzy.
Explain any neurobiological considerations that inform your recommendations.
Explain the benefits and limitations of your recommendations.
Justify your recommendations based on the Learning Resources and current literature.
APA format 7th addition in text citations and full references
Be sure to support your postings and responses with specific references to the Learning Resources.
Lichtblau, L. (2011). Psychopharmacology demystified. Clifton Park, NY: Delmar, Cengage Learning.
Chapter 1, “Neuroanatomy and Neurophysiology” (pp. 1–18)
Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.
Chapter 3, “Neurobiology” (pp. 29–43)
Chapter 4, “Pharmacology” (pp. 45–56)
Chapter 9, “Anxiety Disorders” (pp. 107-122)
National Institute of Neurological Disorders and Stroke. (2014) Brain basics: Understanding sleep Retrieved from https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Understanding-Sleep#sleep_disorders
National Institute of Mental Health. (2016) Mental health medications: Overview. Retrieved from https://www.nimh.nih.gov/health/topics/mental-health-medications/index.shtm